Tammi Noonan
Family · Dubuque, IANPI 1740657287
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (56.1%), food and beverage and education — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Onmark, Inc. at 59.3% of the total. 2025 is the largest year on record at $4,140, more than ten times the $29 reported in 2021. Among family clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 37 payments — averaging $174.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Onmark, Inc.$4K
- US Oncology Corporate, Inc.$2K
- Incyte Corporation$186
- AbbVie$57
- Johnson & Johnson$53
- Myriad Genetic Laboratories, Inc.$27
- plus $62 from 4 others
What the payments were for
- Travel & lodging$3,63056%
- Food & beverage$2,65541%
- Education$1643%
- Gifts$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Onmark, Inc. | 10 | $3,839 |
| US Oncology Corporate, Inc. | 12 | $2,246 |
| Incyte Corporation | 4 | $186 |
| AbbVie | 1 | $57 |
| Johnson & Johnson | 4 | $53 |
| Myriad Genetic Laboratories, Inc. | 2 | $27 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| Bristol Myers Squibb | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
| Novartis | 1 | $12 |
How this compares
$6,469 in reported general payments places this provider in the 95th percentile of 1,268 family providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XtandiEnzalutamide | 40 | $574,900 |
| CalquenceAcalabrutinib Maleate | 32 | $465,376 |
| ImbruvicaIbrutinib | 23 | $186,297 |
| IbrancePalbociclib | 11 | $169,940 |
| VenclextaVenetoclax | 16 | $136,101 |
| Abiraterone Acetate | 16 | $78,868 |
| EliquisApixaban | 47 | $34,655 |
| CreonLipase/Protease/Amylase | 12 | $12,451 |
| XareltoRivaroxaban | 18 | $10,595 |
| Enoxaparin Sodium | 17 | $7,416 |
| Anastrozole | 248 | $3,871 |
| Potassium Chloride | 86 | $1,866 |
| Acyclovir | 115 | $1,719 |
| Hydroxyurea | 61 | $1,357 |
| Letrozole | 50 | $1,172 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncXtandi | $15 | $574,90040 claims |
| AbbVieVenclexta, Creon | $57 | $148,55328 claims |
| Johnson & JohnsonXarelto | $53 | $10,59518 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,268 family providers in Iowa.
Other family in Dubuque
- Hesper NowatzkiDubuque$5K
- Janet LabanDubuque$4K
- Kari ErnstDubuque$4K
- Stefanie GaticaAnkeny$354K
- Aubrey MolgaardAmes$238K
- Joan KittenFort Dodge$85K
- Megan FergusonPella$82K
- Rodney ClarkDes Moines$63K
- Jennifer CondonFort Dodge$31K
- Karen HunkeAmes$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.